SHERI GONZALES: Open Payments
NPI 1437615069 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 37 payments from 11 companies in 2025. Trend: 2023 $466 · 2024 $464 · 2025 $615
Food & beverage: $570Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $161 |
| ABBVIE INC. | 15 | $146 |
| Lilly USA, LLC | 3 | $78 |
| Novo Nordisk Inc | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| PFIZER INC. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: AIRSUPRA, UBRELVY, XIFAXAN, NURTEC ODT, MOUNJARO, Wegovy, FANAPT, QULIPTA.
Industry payments across LA — which companies pay providers there.
